stockrowAgios Pharmaceuticals, Inc. (AGIO) vs Generate Biomedicines, Inc. (GENB)
- Agios Pharmaceuticals, Inc. AGIO 29.41 +4.03%
- Generate Biomedicines, Inc. GENB 13.06 +3.90%
Agios Pharmaceuticals, Inc. and Generate Biomedicines, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Generate Biomedicines, Inc. are of similar size ($1.7B and $1.6B). Agios Pharmaceuticals, Inc. has the higher net margin (−264.8% vs −781.1%) and the lower return on invested capital (−75.0% vs 0.00%). Across the 16 metrics below, Agios Pharmaceuticals, Inc. leads on 11 and Generate Biomedicines, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | GENB | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 100.00% | 68.51% |
| Operating margin | (297.72%) | (751.19%) | 0.00% |
| Net margin | (264.76%) | (781.10%) | 0.00% |
| Free cash flow margin | (238.54%) | (1,692.17%) | 0.00% |
| Return on equity | (32.95%) | 0.00% | (51.96%) |
| Return on assets | (30.44%) | (90.35%) | (46.06%) |
| Return on invested capital | (75.02%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack